{
  "title": "Two recruiting Phase 3 programs",
  "period": "Registry checked 2026-10-07",
  "compiled_on": "2026-10-07",
  "scope": "Selected figures compiled for an unpublished report preview; not a full underlying dataset",
  "methodology": "Selected programs from the report, checked against the ClinicalTrials.gov API. GB-0895’s record was updated on 2026-10-07 and rentosertib’s on 2026-09-17. Trial phase and recruitment status do not establish efficacy, regulatory approval, or how much of development was performed using AI.",
  "rows": [
    {
      "Medicine": "GB-0895",
      "Condition": "Severe asthma",
      "Registry status": "Phase 3 · Recruiting",
      "source_url": "https://clinicaltrials.gov/study/NCT07276724",
      "source_period": "Registry updated 2026-10-07",
      "verification": "Registry API checked 2026-10-07"
    },
    {
      "Medicine": "Rentosertib (INS018_055)",
      "Condition": "Idiopathic pulmonary fibrosis",
      "Registry status": "Phase 3 · Recruiting",
      "source_url": "https://clinicaltrials.gov/study/NCT07687459",
      "source_period": "Registry updated 2026-09-17",
      "verification": "Registry API checked 2026-10-07"
    }
  ]
}